The Defect in the Hurler and Scheie Syndromes: Deficiency of α-L-Iduronidase

  1. Gideon Bach,
  2. Robert Friedman,
  3. Bernard Weissmann, and
  4. Elizabeth F. Neufeld
  1. The National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland 20014
  2. Department of Biochemistry, University of Illinois, College of Medicine, Chicago, Ill. 60612

Abstract

Skin fibroblasts cultured from patients affected with the Hurler or Scheie syndromes (mucopoly-saccharidoses I or V, respectively) have a functional deficiency of a protein required for catabolism of sulfated mucopolysaccharide that has been designated the “Hurler corrective factor.” We now show Hurler factor purified from normal human urine to be associated with α-L-iduronidase activity. Cell lines deficient in Hurler corrective factor have no detectable activity of α-L-iduronidase (less than 3% of that found in cells from individuals of other genotypes). Such correspondence indicates that Hurler corrective factor and α-L-iduronidase are the same entity. Correction of deficient cells is accompanied by an efficient uptake of α-L-iduronidase from the medium.

« Previous | Next Article »Table of Contents